[Prevention of recurrence of acute coronary syndrome].
Koichiro
K
Aihara
Hiroyuki
H
Daida
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000789:Angina, Unstable / Q000209:etiology / Q000517:prevention & control*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D000925:Anticoagulants / Q000008:administration & dosage; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D003324:Coronary Artery Disease / Q000150:complications / Q000517:prevention & control; D003328:Coronary Thrombosis / Q000150:complications / Q000517:prevention & control; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004035:Diet Therapy; D037001:Directive Counseling; D005081:Exercise Therapy; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D012306:Risk; D016540:Smoking Cessation; D013577:Syndrome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D010975:Platelet Aggregation Inhibitors